Octanamide, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-N-[4-(7-hydroxy-2-oxo-2H-1,3-benzoxazin-3(4H)-yl)phenyl]- manufacturers
- MD13
-
-
2026-07-29
- CAS:
- Purity:
- Supply Ability: 10g
|
| | Octanamide, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-N-[4-(7-hydroxy-2-oxo-2H-1,3-benzoxazin-3(4H)-yl)phenyl]- Basic information |
| Product Name: | Octanamide, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-N-[4-(7-hydroxy-2-oxo-2H-1,3-benzoxazin-3(4H)-yl)phenyl]- | | Synonyms: | MD13;MIF degrader MD13;Octanamide, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-N-[4-(7-hydroxy-2-oxo-2H-1,3-benzoxazin-3(4H)-yl)phenyl]- | | CAS: | 2758431-97-7 | | MF: | C35H35N5O8 | | MW: | 653.68 | | EINECS: | | | Product Categories: | | | Mol File: | 2758431-97-7.mol | ![Octanamide, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-N-[4-(7-hydroxy-2-oxo-2H-1,3-benzoxazin-3(4H)-yl)phenyl]- Structure](CAS/20240320/GIF/2758431-97-7.gif) |
| | Octanamide, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-N-[4-(7-hydroxy-2-oxo-2H-1,3-benzoxazin-3(4H)-yl)phenyl]- Chemical Properties |
| Boiling point | 964.5±65.0 °C(Predicted) | | density | 1.434±0.06 g/cm3(Predicted) | | solubility | DMSO:65.37(Max Conc. mg/mL);100.0(Max Conc. mM) | | pka | 8.85±0.20(Predicted) | | form | Solid | | color | Light yellow to yellow |
| | Octanamide, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-N-[4-(7-hydroxy-2-oxo-2H-1,3-benzoxazin-3(4H)-yl)phenyl]- Usage And Synthesis |
| Description | MD13, also known as MIF degrader MD13, is a potent MIF (macrophage migration inhibitory factor) Degrader (PROTAC) (DC50 < 100 nM; Dmax = 92% after 6 h). MD13 comprises the cereblon ligand Pomalidomide joined by a linker to a MIF inhibitor. MD13 reduces MIF levels, arrests cells at the G2/M phase and inhibits proliferation of A549 lung carcinoma cells. Growth of A549 cell 3D spheroids is also inhibited by MDF13. | | Uses | MD13 is a macrophage migration inhibitory factor (MIF)-directed PROTAC with a Ki of 71 nM. MD13 can be used for cancer research[1]. | | storage | Store at -20°C | | References | [1] Xiao Z, et al. Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti-Proliferative Activity in Lung Cancer Cells. Angew Chem Int Ed Engl. 2021 Aug 2;60(32):17514-17521. DOI:10.1002/anie.202101864 |
| | Octanamide, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-N-[4-(7-hydroxy-2-oxo-2H-1,3-benzoxazin-3(4H)-yl)phenyl]- Preparation Products And Raw materials |
|